Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 1
1994 1
1995 1
1996 1
1997 1
1998 2
1999 1
2000 1
2001 1
2002 4
2003 1
2004 4
2005 2
2006 1
2008 4
2009 9
2010 6
2011 5
2012 2
2013 3
2014 3
2015 2
2016 4
2017 5
2018 3
2019 1
2020 6
2021 3
2022 3
2023 1
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, Schoch R, Gattermann N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrom J, Zimmerman L, McKenzie D, Beach C, Silverman LR; International Vidaza High-Risk MDS Survival Study Group. Fenaux P, et al. Among authors: silverman lr. Lancet Oncol. 2009 Mar;10(3):223-32. doi: 10.1016/S1470-2045(09)70003-8. Epub 2009 Feb 21. Lancet Oncol. 2009. PMID: 19230772 Free PMC article. Clinical Trial.
Venetoclax in combination with hypomethylating agents in chronic myelomonocytic leukemia: a propensity score matched multicenter cohort study.
Tremblay D, Csizmar C, DiNardo CD, Ball S, Rippel N, Hammond D, Kadia TM, Ravandi F, Chien K, Van Hyfte G, Mazumdar M, Saliba A, Mangaonkar A, Lasho T, Al-Kali A, Kremyanskaya M, Feld J, Silverman LR, Komrokji R, Mascarenhas J, Padron E, Garcia-Manero G, Sallman DA, Patnaik MM, Montalban-Bravo G. Tremblay D, et al. Among authors: silverman lr. Leukemia. 2025 Jan;39(1):257-260. doi: 10.1038/s41375-024-02466-6. Epub 2024 Nov 12. Leukemia. 2025. PMID: 39533069 No abstract available.
Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy.
Avigan ZM, Catlett J, Bodnar S, Pan D, Aleman A, Sheng T, Moshier E, Rossi AC, Richard S, Kaur G, Richter J, Sanchez LJ, Rodriguez C, Cho HJ, Hussein S, Salib C, Silverman LR, Jagannath S, Parekh S, Thibaud S. Avigan ZM, et al. Among authors: silverman lr. Clin Cancer Res. 2025 Aug 13. doi: 10.1158/1078-0432.CCR-25-1587. Online ahead of print. Clin Cancer Res. 2025. PMID: 40801897
Clinical development of demethylating agents in hematology.
Navada SC, Steinmann J, Lübbert M, Silverman LR. Navada SC, et al. Among authors: silverman lr. J Clin Invest. 2014 Jan;124(1):40-6. doi: 10.1172/JCI69739. Epub 2014 Jan 2. J Clin Invest. 2014. PMID: 24382388 Free PMC article. Review.
76 results